Skip to main content
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.8238
-0.0242 (-2.85%)
At close: Dec 5, 2025, 4:00 PM EST
0.8499
+0.0261 (3.17%)
After-hours: Dec 5, 2025, 7:49 PM EST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending
 Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
Antibody-based Products
11.00M
Log In
Log In
Log In
Log In
Antibody-based Products Growth
4300.00%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending
 Dec '24 Dec '21 Dec '20 Dec '19 Dec '18
United States
11.00M
Log In
Log In
Log In
Log In
United States Growth
4300.00%
Log In
Log In
Log In
Log In